Article
The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients.
PloS one - 1 Jan 2018
Yilmaz Bahtiyar, Spalinger Marianne R, Biedermann Luc, Franc Yannick, Fournier Nicolas, Rossel Jean-Benoit, Juillerat Pascal, Rogler Gerhard, Macpherson Andrew J, Scharl Michael
Abstract excerpt
BACKGROUND: Genetic risk factors, intestinal microbiota and a dysregulated immune system contribute to the pathogenesis of inflammatory bowel disease (IBD). We have previously demonstrated that dysfunction of protein tyrosine phosphatase non-receptor type 2 (PTPN2) and PTPN22 contributes to alterations of intestinal microbiota and the onset of chronic intestinal inflammation in vivo. Here, we investigated the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
